Skip to main content
. 2018 Apr 30;23(5):e12548. doi: 10.1111/anec.12548

Table 3.

Electrocardiographic parameters

SCN5A+ SCN5A−BrS+ (N = 39) Controls (N = 38) p‐value
BrS+ (N = 44) BrS− (N = 35)
PR (ms) 199 ± 28 186 ± 28 157 ± 22 151 ± 24 <.001 a , b , c , d
QRS (ms) 117 ± 22 112 ± 15 106 ± 15 94 ± 10 <.001 a , b , d , e
RR (ms) 919 ± 136 1010 ± 163 853 ± 164 917 ± 152 <.001 a , b
QTc (ms) 416 ± 30 406 ± 20 405 ± 18 414 ± 21 .071
filQRS (ms) 136 ± 23 131 ± 16 123 ± 11 114 ± 10 <.001 a , b , d
RMS40 (μV) 17 ± 12 20 ± 11 20 ± 9 37 ± 20 <.001 b , d , e
LAS40 (ms) 52 ± 17 46 ± 13 42 ± 11 34 ± 11 <.001 a , b , d
LP ≥ 2/3 30 (68%) 22 (63%) 17 (44%) 5 (13%) <.001 b , d , e
fQRS 5 (11%) 6 (17%) 3 (8%) 1 (3%) .19

BrS, Brugada syndrome; filQRS, filtered QRS duration; fQRS, fragmented QRS; LAS40, duration of low amplitude signals < 40 μV; LP, late potentials; RMS40, root mean square of the last 40 ms of the QRS interval.

Bold p‐values indicate significant results.

a

p‐value Tukey post hoc test <.05 between SCN5A+BrS+ and SCN5A−BrS+.

b

p‐value Tukey post hoc test <.05 between SCN5A+BrS+ and controls.

c

p‐value Tukey post hoc test <.05 between SCN5A+BrS− and SCN5A−BrS+.

d

p‐value Tukey post hoc test <.05 between SCN5A+BrS− and controls.

p‐value Tukey post hoc test <.05 between SCN5A+BrS+ and SCN5A+BrS+.

e

p‐value Tukey post hoc test <.05 between SCN5A−BrS+ and controls.